Cargando…
Quality of life in allergic rhinitis patients treated with intralymphatic immunotherapy (ILIT): A 19-year follow-up
BACKGROUND: In 2002-2005, we conducted a phase I/II clinical trial where a new allergy immunotherapy (AIT) route was introduced: intralymphatic immunotherapy (ILIT). Ultrasound guidance allowed injection of allergen directly into inguinal lymph nodes. Grass pollen–allergic patients received 3 inject...
Autores principales: | Adlany, Yasmin K., Šošić, Lara, Senti, Gabriela, Lang, Claudia C.V., Wüthrich, Brunello, Kündig, Thomas M., Johansen, Pål |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509981/ https://www.ncbi.nlm.nih.gov/pubmed/37780115 http://dx.doi.org/10.1016/j.jacig.2022.09.007 |
Ejemplares similares
-
Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans
por: Chabot, Alexandra, et al.
Publicado: (2022) -
Intralymphatic immunotherapy
por: Senti, Gabriela, et al.
Publicado: (2015) -
Intralymphatic Immunotherapy (ILIT) with both grass and birch allergen- a randomized controlled trial
por: Hellkvist, Laila, et al.
Publicado: (2015) -
Efficacy and safety of intralymphatic immunotherapy in allergic rhinitis: A systematic review and meta‐analysis
por: Aini, Nor Rahimah, et al.
Publicado: (2021) -
Evaluation of Intralymphatic Immunotherapy in Allergic Rhinitis Patients: A Systematic Review and Meta-analysis
por: Jiang, Sijie, et al.
Publicado: (2023)